Factors associated with ocular adverse event after immune checkpoint inhibitor treatment
Yong Joon Kim, Jihei Sara Lee, Junwon Lee, Sung Chul Lee, Tae‐im Kim, Suk Ho Byeon, Christopher Seungkyu Lee
Topics & Concepts
MedicineNivolumabDurvalumabTremelimumabPembrolizumabIpilimumabAdverse effectInternal medicineSurgeryDermatologyCancerImmunotherapyCancer Immunotherapy and BiomarkersMelanoma and MAPK PathwaysBrain Metastases and Treatment